These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19945288)

  • 1. Effect of AEE788 and/or Celecoxib on colon cancer cell morphology using advanced microscopic techniques.
    Venkatesan P; Das S; Krishnan MM; Chakraborty C; Chaudhury K; Mandal M
    Micron; 2010 Apr; 41(3):247-56. PubMed ID: 19945288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
    Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
    Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological study of fibroblasts treated with cytochalasin D and colchicine using a confocal laser scanning microscopy.
    Ujihara Y; Miyazaki H; Wada S
    J Physiol Sci; 2008 Dec; 58(7):499-506. PubMed ID: 18928641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer.
    Venkatesan P; Puvvada N; Dash R; Prashanth Kumar BN; Sarkar D; Azab B; Pathak A; Kundu SC; Fisher PB; Mandal M
    Biomaterials; 2011 May; 32(15):3794-806. PubMed ID: 21392822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV; Herzog CR; Rao CV
    Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal regulation of human salivary secretion studied by high resolution electron microscopy and confocal laser microscopy.
    Segawa A; Riva A; Loffredo F; Congiu T; Yamashina S; Testa Riva F
    Eur J Morphol; 1998 Aug; 36 Suppl():41-5. PubMed ID: 9825891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK; Narayanan BA; Reddy BS
    Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
    Yu C; Friday BB; Lai JP; McCollum A; Atadja P; Roberts LR; Adjei AA
    Clin Cancer Res; 2007 Feb; 13(4):1140-8. PubMed ID: 17317822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
    Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
    Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells.
    Motomura W; Nagamine M; Tanno S; Sawamukai M; Takahashi N; Kohgo Y; Okumura T
    J Gastroenterol; 2004; 39(5):461-8. PubMed ID: 15175945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
    Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined action of celecoxib and ionizing radiation in prostate cancer cells is independent of pro-apoptotic Bax.
    Handrick R; Ganswindt U; Faltin H; Goecke B; Daniel PT; Budach W; Belka C; Jendrossek V
    Radiother Oncol; 2009 Mar; 90(3):413-21. PubMed ID: 19038466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
    J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.